N. Cabioglu Et Al. , "Differential expression of novel immunological biomarkers in TILS is associated with improved outcome in advanced triple negative breast cancer resistant to neoadjuvant chemotherapy," BREAST , vol.44, 2019
Cabioglu, N. Et Al. 2019. Differential expression of novel immunological biomarkers in TILS is associated with improved outcome in advanced triple negative breast cancer resistant to neoadjuvant chemotherapy. BREAST , vol.44 .
Cabioglu, N., Onder, S., Oner, G., Karatay, H., Ozkurt, E., Trablus, D. C., ... Tukenmez, M.(2019). Differential expression of novel immunological biomarkers in TILS is associated with improved outcome in advanced triple negative breast cancer resistant to neoadjuvant chemotherapy. BREAST , vol.44.
Cabioglu, Neslihan Et Al. "Differential expression of novel immunological biomarkers in TILS is associated with improved outcome in advanced triple negative breast cancer resistant to neoadjuvant chemotherapy," BREAST , vol.44, 2019
Cabioglu, Neslihan Et Al. "Differential expression of novel immunological biomarkers in TILS is associated with improved outcome in advanced triple negative breast cancer resistant to neoadjuvant chemotherapy." BREAST , vol.44, 2019
Cabioglu, N. Et Al. (2019) . "Differential expression of novel immunological biomarkers in TILS is associated with improved outcome in advanced triple negative breast cancer resistant to neoadjuvant chemotherapy." BREAST , vol.44.
@article{article, author={Neslihan CABIOĞLU Et Al. }, title={Differential expression of novel immunological biomarkers in TILS is associated with improved outcome in advanced triple negative breast cancer resistant to neoadjuvant chemotherapy}, journal={BREAST}, year=2019}